Timion A. Meijs

Timion A. Meijs

Auto-generated profile, based on publicly available information

Timion A. Meijs

Department of Cardiology, University Medical Center Utrecht, Utrecht, the Netherlands

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 November 2021 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
TMTimion A. Meijs
Timion A. Meijs
SMSavine C. S. Minderhoud
Savine C. S. Minderhoud
SMSteven A. Muller
Steven A. Muller
RWRobbert J. de Winter
Robbert J. de Winter
BMBarbara J. M. Mulder
Barbara J. M. Mulder
MVMichiel Voskuil
Michiel Voskuil
Background: The long‐term burden of cardiovascular disease after repair of coarctation of the aorta (CoA) has not been elucidated. We aimed to determine the incidence of and risk factors for cardiovascular events in adult patients with repaired CoA. Additionally, mortality rates were compared between adults with repaired CoA and the general population. Methods and Results: Using the Dutch Congenital Corvitia (CONCOR) registry, patients aged ≥16 years with previous surgical or transcatheter CoA repair from 5 tertiary referral centers were included. Cardiovascular events were recorded, comprising coronary artery disease, stroke/transient ischemic attack, aortic complications, arrhythmias, heart failure hospitalizations, endocarditis, and cardiovascular death. In total, 920 patients (median age, 24 years [range 16–74 years]) were included. After a mean follow‐up of 9.3±5.1 years, 191 patients (21%) experienced at least 1 cardiovascular event. A total of 270 cardiovascular events occurred, of which aortic complications and arrhythmias were most frequent. Older age at initial CoA repair (hazard ratio [HR], 1.017; 95% CI, 1.000–1.033 [ P =0.048]) and elevated left ventricular mass index (HR, 1.009; 95% CI, 1.005–1.013 [ P <0.001]) were independently associated with an increased risk of cardiovascular events. The mortality rate was 3.3 times higher than expected based on an age‐ and sex‐matched cohort from the Dutch general population (standardized mortality ratio, 3.3; 95% CI, 2.3–4.4 [ P <0.001]). Conclusions: This large, prospective cohort of adults with repaired CoA showed a high burden of cardiovascular events, particularly aortic complications and arrhythmias, during long‐term follow‐up. Older age at initial CoA repair and elevated left ventricular mass index were independent risk factors for the occurrence of cardiovascular events. Mortality was 3.3‐fold higher compared with the general population. These results advocate stringent follow‐up after CoA repair and emphasize the need for improved preventive strategies.

25 September 2019 in Mini-Reviews in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
MPMarijn M.C. Peters
Marijn M.C. Peters
TMTimion A. Meijs
Timion A. Meijs
WGWouter Gathier
Wouter Gathier
PDPieter A.M. Doevendans
Pieter A.M. Doevendans
JSJoost P.G. Sluijter
Joost P.G. Sluijter
KNKlaus Neef
Klaus Neef
: Follistatin-like 1 (FSTL1), a secreted glycoprotein, has been shown to participate in regulating developmental processes and to be involved in states of disease and injury. Spatiotemporal regulation and posttranslational modifications contribute to its specific functions and make it an intriguing candidate to study disease mechanisms and potentially develop new therapies. With cardiovascular diseases as the primary cause of death worldwide, clarification of mechanisms underlying cardiac regeneration and revascularization remains essential. Recent findings on FSTL1 in both acute coronary syndrome and heart failure emphasize its potential as a target for cardiac regenerative therapy. With this review, we aim to shed light on the role of FSTL1 specifically in cardiovascular disease and inflammation.

19 June 2017 in Netherlands Heart Journal
Verified
Journal Article
Open access
PDF file
EHE. A. Hart
E. A. Hart
TMT. A. Meijs
T. A. Meijs
RMR. C. A. Meijer
R. C. A. Meijer
KDKoen M.A. Dreijerink
Koen M.A. Dreijerink
MTM. E. Tesselaar
M. E. Tesselaar
SCS. A. J. Chamuleau
S. A. J. Chamuleau
The cardiac manifestations of a neuroendocrine tumour are referred to as carcinoid heart disease (CaHD) and are associated with a poor prognosis. Surgical intervention is the only proven therapeutic option and may prolong survival and quality of life. No consensus has been reached internationally with regard to screening for CaHD and the optimal timing for surgery. Although limited evidence is available on this matter, a trend towards early surgery and subsequent reduced mortality has been observed. In this review we provide an overview of the current understanding and propose a protocol to guide cardiologists in the screening for CaHD and the timing of referral to a specialised surgical centre.

17 July 2019 in Heart
Verified
Journal Article
Closed access
TMTimion A Meijs
Timion A Meijs
EWEvangeline G Warmerdam
Evangeline G Warmerdam
MSMartijn G Slieker
Martijn G Slieker
GKGregor J Krings
Gregor J Krings
MMMirella M C Molenschot
Mirella M C Molenschot
MVMichiel Voskuil
Michiel Voskuil
Objective: Long-term prognosis of patients with coarctation of the aorta (CoA) is impaired due to the high prevalence of hypertension and consequent cardiovascular complications. Although stent implantation results in acute anatomical and haemodynamic benefit, limited evidence exists regarding the late clinical outcome. In this meta-analysis, we aimed to evaluate the medium-term effect of stent placement for CoA on systemic blood pressure (BP). Methods: PubMed, EMBASE and Cochrane databases were searched for non-randomised cohort studies addressing systemic BP ≥12 months following CoA stenting. Meta-analysis was performed on the change in BP from baseline to last follow-up using a random-effects model. Subgroup analyses and meta-regression were conducted to identify sources of heterogeneity between studies. Results: Twenty-six studies with a total of 1157 patients and a median follow-up of 26 months were included for final analysis. Meta-analysis showed a 20.3 mm Hg (95% CI 16.4 to 24.1 mm Hg; p<0.00001) reduction in systolic BP and an 8.2 mm Hg (12 studies; 95% CI 5.2 to 11.3 mm Hg; p<0.00001) reduction in diastolic BP. A concomitant decrease in the use of antihypertensive medication was observed. High systolic BP and peak systolic gradient at baseline and stenting of native CoA were associated with a greater reduction in systolic BP at follow-up. Conclusions: Stent implantation for CoA is associated with a significant decline in systolic and diastolic BP during medium-term follow-up. The degree of BP reduction appears to be dependent on baseline systolic BP, baseline peak systolic gradient, and whether stenting is performed for native or recurrent CoA.

1 April 2017 in International Journal of Cardiology
Verified
Journal Article
Closed access
EHE.A. Hart
E.A. Hart
RJR. Jansen
R. Jansen
TMT.A. Meijs
T.A. Meijs
BBB.J. Bouma
B.J. Bouma
RRR.K. Riezebos
R.K. Riezebos
SCS.A.J. Chamuleau
S.A.J. Chamuleau

3 October 2016 in Journal of Hand Surgery (European Volume)
Verified
Journal Article
Closed access
AMAli Moradi
Ali Moradi
YBY. Braun
Y. Braun
KOK. Oflazoglu
K. Oflazoglu
TMT. Meijs
T. Meijs
DRD. Ring
D. Ring
NCN. Chen
N. Chen
Radiographs and medical record of all adult patients with a mallet fracture in three hospitals between 2004 and 2014 were reviewed. International Classification of Diseases, Ninth Revision (ICD-9) codes and text search in radiographic reports were used to identify all acute patients with potential mallet fractures in our institutional database. Manually checking, 392 true mallet fractures were identified among them, 78 had subluxation at the time of diagnosis and 19 had subluxation at a later time point during treatment. Fragment size, fragment displacement, and interval between injury and treatment were associated with initial and late subluxation. Subluxation was not observed when the fracture size was less than 39% of the total articular surface. For each 1% increase in total articular surface involvement in fractures with more than 39% involvement, the risk of subluxation increased by 4% and for each 1% of displacement, the risk of subluxation increased by 4%. Level of Evidence: IV